Osong Public Health and Research Perspectives

From articles published in Osong Public Health and Research Perspectives during the past two years (2021 ~ ).

Original Article

Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria: Oluseyi Ademola Adejumo, Olorunfemi Akinbode Ogundele, Cynthia Roli Madubuko, Rosena Olubanke Oluwafemi, Ogochukwu Chinedum Okoye, Kenechukwu Chukwuemeka Okonkwo, Sunday Samson Owolade, Oladimeji Adedeji Junaid, Olutoyin Morenike Lawal, Adenike Christianah Enikuomehin, Maureen Iru Ntaji, Aisha Sokunbi, Aina Omodele Timothy, Olatunji Sunday Abolarin, Emmanuel Olalekan Ali, John Oghenevwirhe Ohaju-Obodo; Osong Public Health Res Perspect. 2021;12(4):236-243. Published online July 19, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0023

7,231 View
402 Download
21 Citations

Objectives
The study aimed to examine health workers’ perceptions of the coronavirus disease 2019 (COVID-19) vaccine in Nigeria and their willingness to receive the vaccine when it becomes available.
Methods
This multi-center cross-sectional study used non-probability convenience sampling to enroll 1,470 hospital workers aged 18 and above from 4 specialized hospitals. A structured and validated self-administered questionnaire was used for data collection. Data entry and analysis were conducted using IBM SPSS ver. 22.0.
Results
The mean age of respondents was 40±6 years. Only 53.5% of the health workers had positive perceptions of the COVID-19 vaccine, and only slightly more than half (55.5%) were willing to receive vaccination. Predictors of willingness to receive the COVID-19 vaccine included having a positive perception of the vaccine (adjusted odds ratio [AOR], 4.55; 95% confidence interval [CI], 3.50−5.69), perceiving a risk of contracting COVID-19 (AOR, 1.50; 95% CI, 1.25–3.98), having received tertiary education (AOR, 3.50; 95% CI, 1.40−6.86), and being a clinical health worker (AOR, 1.25; 95% CI, 1.01−1.68).
Conclusion
Perceptions of the COVID-19 vaccine and willingness to receive the vaccine were sub-optimal among this group. Educational interventions to improve health workers' perceptions and attitudes toward the COVID-19 vaccine are needed.

Citations

Citations to this article as recorded by

‘Why Should I Take the COVID-19 Vaccine after Recovering from the Disease?’ A Mixed-methods Study of Correlates of COVID-19 Vaccine Acceptability among Health Workers in Northern Nigeria
Zubairu Iliyasu, Muhammad R. Garba, Auwalu U. Gajida, Taiwo G. Amole, Amina A. Umar, Hadiza M. Abdullahi, Aminatu A. Kwaku, Hamisu M. Salihu, Muktar H. Aliyu
Pathogens and Global Health.2022; 116(4): 254. CrossRef
Suspecting the Figures: What Church Leaders Think About Government’s Commitment to Combating COVID-19 in Nigeria
Uchechukwu M. Agbo, George C. Nche
Journal of Asian and African Studies.2022; : 002190962110696. CrossRef
A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review
Malik Sallam, Mariam Al-Sanafi, Mohammed Sallam
Journal of Multidisciplinary Healthcare.2022; Volume 15: 21. CrossRef
Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey
Meliha Cagla Sonmezer, Taha Koray Sahin, Enes Erul, Furkan Sacit Ceylan, Muhammed Yusuf Hamurcu, Nihal Morova, Ipek Rudvan Al, Serhat Unal
Vaccines.2022; 10(2): 278. CrossRef
Factors influencing COVID-19 vaccine uptake among adults in Nigeria
Halimat Adedeji-Adenola, Olubusola A. Olugbake, Shakirat A. Adeosun, Ismaeel Yunusa
PLOS ONE.2022; 17(2): e0264371. CrossRef
Perception and Prevention Practices Relating to Covid 19 Infection Among Elderly in Ogun State, Nigeria
Adenitire G., Agbede C.O.
International Journal of Public Health and Pharmac.2022; 2(1): 29. CrossRef
Predicting nursing students' intention to attend face‐to‐face classes on school reopening: A theory of planned behavior application
Ryan Michael F. Oducado, Jerome V. Cleofas, Gil P. Soriano
Nursing Forum.2022; 57(5): 733. CrossRef
COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors
Oluwatosin Olu-Abiodun, Olumide Abiodun, Ngozi Okafor, Nusirat Elelu
PLOS ONE.2022; 17(5): e0267691. CrossRef
COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis
Martin Ackah, Louise Ameyaw, Mohammed Gazali Salifu, Delali Pearl Afi Asubonteng, Cynthia Osei Yeboah, Eugene Narkotey Annor, Eunice Abena Kwartemaa Ankapong, Hosea Boakye, Muhammad Shahzad Aslam
PLOS ONE.2022; 17(5): e0268711. CrossRef
A national survey of COVID-19 vaccine acceptance in Nigeria
Ahmad Ibrahim Al-Mustapha, Ochulor Okechukwu, Ademola Olayinka, Oyeniyi Rasheed Muhammed, Muftau Oyewo, Samuel A. Owoicho, Ahmed Tijani Abubakar, Abdulsalam Olabisi, Aliyu Jibril, Simon Ereh, Oluwatosin Enoch Fakayode, Oluwaseun Adeolu Ogundijo, Nusirat E
Vaccine.2022; 40(33): 4726. CrossRef
Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study
Rafaella Fortini Queiroz Grenfell, Oyetunde Timothy Oyeyemi
Pathogens and Global Health.2022; : 1. CrossRef
COVID-19 vaccine hesitancy in Africa: a scoping review
Betty B. B. Ackah, Michael Woo, Lisa Stallwood, Zahra A. Fazal, Arnold Okpani, Ugochinyere Vivian Ukah, Prince A. Adu
Global Health Research and Policy.2022;[Epub] CrossRef
COVID-19 Vaccine Acceptance and Associated Factors Among College Students in Dessie City, Northeastern Ethiopia
Gete Berihun, Zebader Walle, Daniel Teshome, Leykun Berhanu, Mohammed Derso
Journal of Multidisciplinary Healthcare.2022; Volume 15: 1735. CrossRef
Career Aspiration Fulfillment and COVID-19 Vaccination Intention among Nigerian Youth: An Instrumental Variable Approach
Abayomi Samuel Oyekale
International Journal of Environmental Research an.2022; 19(16): 9813. CrossRef
COVID-19 Vaccine Attitude and Its Predictors Among People Living With Chronic Health Conditions in Ibadan, Nigeria
Lucia Yetunde Ojewale, Rotimi Felix Afolabi, Adesola Ogunniyi
International Journal of Public Health.2022;[Epub] CrossRef
Associations between COVID-19 vaccine hesitancy and the experience of violence among women and girls living with and at risk of HIV in Nigeria
Morenike Oluwatoyin Folayan, Olujide Arije, Amaka Enemo, Aaron Sunday, Amira Muhammad, Hasiya Yunusa Nyako, Rilwan Mohammed Abdullah, Henry Okiwu, Erik Lamontagne
African Journal of AIDS Research.2022; 21(4): 306. CrossRef
Willingness to receive COVID-19 vaccine: A survey among medical radiation workers in Nigeria
Grace Ben Inah, Samuel Archibong Efanga, Ekaete Vincent Ukpong, Christiana Ifeyinwa Obiora
Calabar Journal of Health Sciences.2022; 6: 80. CrossRef
Acceptance of COVID-19 vaccine among healthcare workers in Africa, systematic review and meta-analysis
Zerihun Figa, Tesfaye Temesgen, Addisu Getnet Zemeskel, Moges Ganta, Asrat Alemu, Mesfin Abebe, Zemachu Ashuro
Public Health in Practice.2022; 4: 100343. CrossRef
Perception and willingness to accept COVID-19 Vaccines: A cross-sectional survey of the general population of Sokoto State, Nigeria
Oche Mansur Oche, Habibullah Adamu, Musa Yahaya, Hudu Garba Illo, Abdulaziz Mohammad Danmadami, Adamu Ijapa, Asmau Mohammad Wali, Hamza Yusuf, Hafsat Muhammad, Abba Aji, Harapan Harapan
PLOS ONE.2022; 17(12): e0278332. CrossRef
COVID-19 vaccination acceptance among community members and health workers in Ebonyi state, Nigeria: study protocol for a concurrent-independent mixed method analyses of intention to receive, timeliness of the intention to receive, uptake and hesitancy to
Ugwu I Omale, Osarhiemen Iyare, Richard L Ewah, Chidinma I Amuzie, Onyinyechukwu U Oka, Victor U Uduma, Azuka S Adeke, Cordis O Ikegwuonu, Olaedo O Nnachi, Okechukwu O Ukpabi, Ifeyinwa M Okeke, Glory E Nkwo, Ugochi IA Nwali
BMJ Open.2022; 12(12): e061732. CrossRef
Drivers of COVID-19 Vaccine Uptake amongst Healthcare Workers (HCWs) in Nigeria
Sohail Agha, Adaobi Chine, Mathias Lalika, Samikshya Pandey, Aparna Seth, Alison Wiyeh, Alyssa Seng, Nandan Rao, Akhtar Badshah
Vaccines.2021; 9(10): 1162. CrossRef

Brief Reports

Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020: Ae Kyung Park, Il-Hwan Kim, Junyoung Kim, Jeong-Min Kim, Heui Man Kim, Chae young Lee, Myung-Guk Han, Gi-Eun Rhie, Donghyok Kwon, Jeong-Gu Nam, Young-Joon Park, Jin Gwack, Nam-Joo Lee, SangHee Woo, Jin Sun No, Jaehee Lee, Jeemin Ha, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim; Osong Public Health Res Perspect. 2021;12(1):37-43. Published online February 23, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.12.1.06

5,229 View
194 Download
16 Citations

Abstract PDF

Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22^nd, 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25^th, 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea.

Citations

Citations to this article as recorded by

Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
Ae Kyung Park, Il-Hwan Kim, Chae Young Lee, Jeong-Ah Kim, Hyeokjin Lee, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Jaehee Lee, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
Annals of Laboratory Medicine.2023; 43(2): 211. CrossRef
Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea
Ae Kyung Park, Jee Eun Rhee, Il‐Hwan Kim, Heui Man Kim, Hyeokjin Lee, Jeong‐Ah Kim, Chae Young Lee, Nam‐Joo Lee, SangHee Woo, Jaehee Lee, Jin Sun No, Gi‐Eun Rhie, Seong Jin Wang, Sang‐Eun Lee, Young Joon Park, Gemma Park, Jung Yeon Kim, Jin Gwack, Cheon‐K
Journal of Medical Virology.2022; 94(4): 1717. CrossRef
SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021
Ae Kyung Park, Il-Hwan Kim, Heui Man Kim, Hyeokjin Lee, Nam-Joo Lee, Jeong-Ah Kim, SangHee Woo, Chae young Lee, Jaehee Lee, Sae Jin Oh, JeeEun Rhee, Cheon-Kwon Yoo, Eun-Jin Kim
Emerging Infectious Diseases.2022; 28(2): 415. CrossRef
Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals
Ji-Young Hwang, Yunhwa Kim, Kyung-Min Lee, Eun-Jeong Jang, Chang-Hoon Woo, Chang-Ui Hong, Seok-Tae Choi, Sivilay Xayaheuang, Jong-Geol Jang, June-Hong Ahn, Hosun Park
Vaccines.2022; 10(2): 332. CrossRef
Increase in Viral Load in Patients With SARS-CoV-2 Delta Variant Infection in the Republic of Korea
Jeong-Min Kim, Jee Eun Rhee, Myeongsu Yoo, Heui Man Kim, Nam-Joo Lee, Sang Hee Woo, Hye-Jun Jo, Donghyok Kwon, Sangwon Lee, Cheon Kwon Yoo, Eun-Jin Kim
Frontiers in Microbiology.2022;[Epub] CrossRef
Molecular Dynamics Studies on the Structural Stability Prediction of SARS-CoV-2 Variants Including Multiple Mutants
Kwang-Eun Choi, Jeong-Min Kim, Jee Eun Rhee, Ae Kyung Park, Eun-Jin Kim, Cheon Kwon Yoo, Nam Sook Kang
International Journal of Molecular Sciences.2022; 23(9): 4956. CrossRef
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients
Jee-Soo Lee, Ki Wook Yun, Hyeonju Jeong, Boram Kim, Man Jin Kim, Jae Hyeon Park, Ho Seob Shin, Hyeon Sae Oh, Hobin Sung, Myung Gi Song, Sung Im Cho, So Yeon Kim, Chang Kyung Kang, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Myoung-Don Oh, Eun Hwa Choi
Virulence.2022; 13(1): 1242. CrossRef
Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant
Sunhee Lee, Gun Young Yoon, Su Jin Lee, Young-Chan Kwon, Hyun Woo Moon, Yu-Jin Kim, Haesoo Kim, Wooseong Lee, Gi Uk Jeong, Chonsaeng Kim, Kyun-Do Kim, Seong-Jun Kim, Dae-Gyun Ahn, Miguel Angel Martinez
Microbiology Spectrum.2022;[Epub] CrossRef
Clinical scoring system to predict viable viral shedding in patients with COVID-19
Sung Woon Kang, Heedo Park, Ji Yeun Kim, Sunghee Park, So Yun Lim, Sohyun Lee, Joon-Yong Bae, Jeonghun Kim, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Yang Soo Kim, Sung-Cheol Yun, Man-Seong Park, Sung-Han Kim
Journal of Clinical Virology.2022; 157: 105319. CrossRef
Model-informed COVID-19 exit strategy with projections of SARS-CoV-2 infections generated by variants in the Republic of Korea
Sung-mok Jung, Kyungmin Huh, Munkhzul Radnaabaatar, Jaehun Jung
BMC Public Health.2022;[Epub] CrossRef
Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins
Sanghoo Lee, Mi-Kyeong Lee, Hyeongkyun Na, Jinwoo Ahn, Gayeon Hong, Youngkee Lee, Jimyeong Park, Yejin Kim, Yun-Tae Kim, Chang-Ki Kim, Hwan-Sub Lim, Kyoung-Ryul Lee
Gene Reports.2021; 23: 101100. CrossRef
Review of Current COVID-19 Diagnostics and Opportunities for Further Development
Yan Mardian, Herman Kosasih, Muhammad Karyana, Aaron Neal, Chuen-Yen Lau
Frontiers in Medicine.2021;[Epub] CrossRef
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants
Manish Raturi, Anuradha Kusum, Mansi Kala, Garima Mittal, Anita Sharma, Naveen Bansal
Transfusion Clinique et Biologique.2021; 28(3): 300. CrossRef
Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2
Kwang-Eun Choi, Jeong-Min Kim, JeeEun Rhee, Ae Kyung Park, Eun-Jin Kim, Nam Sook Kang
International Journal of Molecular Sciences.2021; 22(16): 8714. CrossRef
Management following the first confirmed case of SARS-CoV-2 in a domestic cat associated with a massive outbreak in South Korea
Taewon Han, Boyeong Ryu, Suyeon Lee, Yugyeong Song, Yoongje Jeong, Ilhwan Kim, Jeongmin Kim, Eunjin Kim, Wonjun Lee, Hyunju Lee, Haekyoung Hwang
One Health.2021; 13: 100328. CrossRef
Genomic epidemiology reveals the reduction of the introduction and spread of SARS-CoV-2 after implementing control strategies in Republic of Korea, 2020
Jung-Hoon Kwon, Jeong-Min Kim, Dong-hun Lee, Ae Kyung Park, Il-Hwan Kim, Da-Won Kim, Ji-Yun Kim, Noori Lim, Kyeong-Yeon Cho, Heui Man Kim, Nam-Joo Lee, SangHee Woo, Chae Young Lee, Jin Sun No, Junyoung Kim, JeeEun Rhee, Myung-Guk Han, Gi-Eun Rhie, Cheon K
Virus Evolution.2021;[Epub] CrossRef

COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021: Insob Hwang, Kyeongeun Park, Tae Eun Kim, Yunhyung Kwon, Yeon-Kyeng Lee; Osong Public Health Res Perspect. 2021;12(6):396-402. Published online December 21, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0310

4,476 View
159 Download
7 Citations

Graphical Abstract Abstract PDF Supplementary Material

Objectives
This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an analysis of the characteristics of suspected adverse event cases for each type of vaccine.
Methods
Adverse events following COVID-19 vaccination reported by medical doctors and forensic pathologists were analyzed. Cases of suspected anaphylaxis were classified using the Brighton Collaboration definition.
Results
By October 31, 2021, a total of 353,535 (0.45%) adverse events were reported after 78,416,802 COVID-19 vaccine doses. Of the adverse events, 96.4% were non-serious and 3.6% were serious. The most frequently reported adverse events were headache, myalgia, and dizziness. Of the 835 reported deaths after COVID-19 vaccination, 2 vaccine-related deaths were confirmed. Suspected anaphylaxis was confirmed in 454 cases using the Brighton Collaboration definition.
Conclusion
The commonly reported symptoms were similar to those described in clinical trials. Most reported adverse events were non-serious, and the reporting rate of adverse events following COVID-19 vaccination was higher in women than in men (581 vs. 315 per 100,000 vaccinations). Confirmed anaphylaxis was reported in 5.8 cases per 1,000,000 vaccinations.

Citations

Citations to this article as recorded by

Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management
Nicoletta Luxi, Alexia Giovanazzi, Alessandra Arcolaci, Patrizia Bonadonna, Maria Angiola Crivellaro, Paola Maria Cutroneo, Carmen Ferrajolo, Fabiana Furci, Lucia Guidolin, Ugo Moretti, Elisa Olivieri, Giuliana Petrelli, Giovanna Zanoni, Gianenrico Senna,
BioDrugs.2022; 36(4): 443. CrossRef
Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea
Seontae Kim, Insob Hwang, Mijeong Ko, Yunhyung Kwon, Yeon-Kyeng Lee
Osong Public Health and Research Perspectives.2022; 13(3): 230. CrossRef
Incidence and Characteristics of Adverse Events after COVID-19 Vaccination in a Population-Based Programme
Laura Bonzano, Olivera Djuric, Pamela Mancuso, Lidia Fares, Raffaele Brancaccio, Marta Ottone, Eufemia Bisaccia, Massimo Vicentini, Alessia Cocconcelli, Alfonso Motolese, Rostyslav Boyko, Paolo Giorgi Rossi, Alberico Motolese
Vaccines.2022; 10(7): 1111. CrossRef
Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review
Carla Pires
Vaccines.2022; 10(8): 1349. CrossRef
Anaphylaxis and Related Events Following COVID‐19 Vaccination: A Systematic Review
Pradipta Paul, Emmad Janjua, Mai AlSubaie, Vinutha Ramadorai, Beshr Mushannen, Ahamed Lazim Vattoth, Wafa Khan, Khalifa Bshesh, Areej Nauman, Ibrahim Mohammed, Imane Bouhali, Mohammed Khalid, Dalia Zakaria
The Journal of Clinical Pharmacology.2022; 62(11): 1335. CrossRef
Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years
Seontae Kim, Yeseul Heo, Soon-Young Seo, Do Sang Lim, Enhi Cho, Yeon-Kyeng Lee
Osong Public Health and Research Perspectives.2022; 13(5): 382. CrossRef
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward
Eliel Nham, Joon Young Song, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim
Journal of Korean Medical Science.2022;[Epub] CrossRef

Review Article

Social determinants of adherence to COVID-19 preventive guidelines: a comprehensive review: Zahra Jorjoran Shushtari, Yahya Salimi, Sina Ahmadi, Nader Rajabi-Gilan, Marzieh Shirazikhah, Akbar Biglarian, Ali Almasi, Mohammad Ali Mohammadi Gharehghani; Osong Public Health Res Perspect. 2021;12(6):346-360. Published online December 21, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0180

3,619 View
121 Download
7 Citations

Graphical Abstract Abstract PDF Supplementary Material

Adherence to coronavirus disease 2019 (COVID-19) preventive guidelines (ACPG) is an important strategy to control the COVID-19 pandemic effectively. The present study aimed to identify and summarize the social determinants of ACPG among the general population. A comprehensive review was performed from December 2019 to February 2021 through searching electronic databases. Two independent reviewers assessed and selected relevant studies. Next, the characteristics and main findings of the included studies were summarized. Finally, the World Health Organization’s conceptual framework of social determinants of health was used to synthesize the identified social determinants of ACPG. Forty-one of 453 retrieved articles met the inclusion criteria. The study results showed different patterns of ACPG among various communities. Furthermore, 84 social determinants were identified and categorized into structural and intermediary determinants. ACPG is a set of complex behaviors associated with different individual sociodemographic and behavioral characteristics; living and working conditions; COVID-19 knowledge, attitudes, and risk perceptions; exposure to sources and information level; leisure activities; social support; trust; social norms; psychosocial well-being; socio-economic position; and the socio-economic and political context. Interventions to promote ACPG among the general population should consider the identified social determinants of ACPG.

Citations

Citations to this article as recorded by

Social Determinants of Adherence to COVID-19 Preventive Guidelines in Iran: A Qualitative Study
Sina Ahmadi, Zahra Jorjoran Shushtari, Marzieh Shirazikhah, Akbar Biglarian, Seyed Fahim Irandoost, Toktam Paykani, Ali Almasi, Nader Rajabi-Gilan, Nafiul Mehedi, Yahya Salimi
INQUIRY: The Journal of Health Care Organization, .2022; 59: 004695802210841. CrossRef
Determinants of observing health protocols related to preventing COVID-19 in adult women: A qualitative study in Iran
Javad Yoosefi Lebni, Saeede Pavee, Mandana Saki, Arash Ziapour, Ahmad Ahmadi, Mehdi Khezeli
Frontiers in Public Health.2022;[Epub] CrossRef
Adherence to Coronavirus Disease 2019 Preventive Measures in a Representative Sample of the Population of the Canton of Vaud, Switzerland
Audrey Butty, Nolwenn Bühler, Jérôme Pasquier, Julien Dupraz, Vincent Faivre, Sandrine Estoppey, Cloé Rawlinson, Semira Gonseth Nusslé, Murielle Bochud, Valérie D’Acremont
International Journal of Public Health.2022;[Epub] CrossRef
Cognitive predictors of COVID-19 mitigation behaviors in vaccinated and unvaccinated general population members
Anna Hudson, Peter A. Hall, Sara C. Hitchman, Gang Meng, Geoffrey T. Fong
Vaccine.2022;[Epub] CrossRef
Quarantine preparedness – the missing factor in COVID-19 behaviour change? Qualitative insights from Australia
Angela Davis, Stephanie Munari, Joseph Doyle, Brett Sutton, Allen Cheng, Margaret Hellard, Lisa Gibbs
BMC Public Health.2022;[Epub] CrossRef
The impact of COVID-19 pandemic on hospital admissions for nine diseases in Iran: insight from an interrupted time series analysis
Sina Ahmadi, Ali Kazemi-Karyani, Nasim Badiee, Sarah Byford, Ali Mohammadi, Bakhtiar Piroozi, Satar Rezaei
Cost Effectiveness and Resource Allocation.2022;[Epub] CrossRef
Psychosocial Determinants of Hand Hygiene, Facemask Wearing, and Physical Distancing During the COVID-19 Pandemic: A Systematic Review and Meta-analysis
Wei Liang, Yanping Duan, Feifei Li, Ryan E Rhodes, Xiang Wang, Dehiwala Liyanage Ishanka Harshani Kusum Peiris, Lin Zhou, Borui Shang, Yide Yang, Julien S Baker, Jiao Jiao, Wei Han
Annals of Behavioral Medicine.2022; 56(11): 1174. CrossRef

Original Article

Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey: June Fei Wen Lau, Yuan Liang Woon, Chin Tho Leong, Hoon Shien Teh; Osong Public Health Res Perspect. 2021;12(6):361-373. Published online November 25, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0085

8,384 View
436 Download
7 Citations

Abstract PDF Supplementary Material

Objectives
The coronavirus disease 2019 (COVID-19) pandemic has set a precedent for the fastest-produced vaccine as a result of global collaboration and outreach. This study explored Malaysians’ acceptance of the COVID-19 vaccine and its associated factors.
Methods
A cross-sectional anonymous web-based survey was disseminated to Malaysian adults aged ≥18 years old via social media platforms between July 10, 2020 and August 31, 2020.
Results
In the analysis of 4,164 complete responses, 93.2% of participants indicated that they would accept the COVID-19 vaccine if it was offered for free by the Malaysian government. The median out-of-pocket cost that participants were willing to pay for a COVID-19 vaccine was Malaysian ringgit (MYR) 100 (interquartile range [IQR], 100) if it was readily available and MYR 150 (IQR, 200) if the supply was limited. Respondents with a low likelihood of vaccine hesitancy had 13 times higher odds of accepting the COVID-19 vaccine (95% confidence interval [CI], 8.69 to 19.13). High perceived risk and severity were also associated with willingness to be vaccinated, with adjusted odds ratios of 2.22 (95% CI, 1.44 to 3.41) and 2.76 (95% CI, 1.87 to 4.09), respectively. Age and ethnicity were the only independent demographic characteristics that predicted vaccine uptake.
Conclusion
Public health strategies targeting perceived risk, perceived susceptibility and vaccine hesitancy could be effective in enhancing vaccine uptake.

Citations

Citations to this article as recorded by

Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece
Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
Vacunas.2022; 23: S60. CrossRef
Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework
Jason Wei Jian Ng, Santha Vaithilingam, Mahendhiran Nair, Li-Ann Hwang, Kamarul Imran Musa, Anat Gesser-Edelsburg
PLOS ONE.2022; 17(5): e0268926. CrossRef
Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
Li Ping Wong, Haridah Alias, Yan-Li Siaw, Mustakiza Muslimin, Lee Lee Lai, Yulan Lin, Zhijian Hu
Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis
Ayenew Mose, Abebaw Wasie, Solomon Shitu, Kassahun Haile, Abebe Timerga, Tamirat Melis, Tadesse Sahle, Amare Zewdie, Dong Keon Yon
PLOS ONE.2022; 17(6): e0269273. CrossRef
When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioural insights from a randomised controlled experiment in Malaysia
Nicholas Yee Liang Hing, Yuan Liang Woon, Yew Kong Lee, Hyung Joon Kim, Nurhyikmah M Lothfi, Elizabeth Wong, Komathi Perialathan, Nor Haryati Ahmad Sanusi, Affendi Isa, Chin Tho Leong, Joan Costa-Font
BMJ Global Health.2022; 7(7): e009250. CrossRef
COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis
Getaneh Mulualem Belay, Tewodros Getaneh Alemu, Masresha Asmare Techane, Chalachew Adugna Wubneh, Nega Tezera Assimamaw, Tadesse Tarik Tamir, Addis Bilal Muhye, Destaye Guadie Kassie, Amare Wondim, Bewuketu Terefe, Bethlehem Tigabu Tarekegn, Mohammed Seid
Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece
Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
Vacunas (English Edition).2022; 23: S60. CrossRef

Review Article

Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide: Yeonju Kim, Eun-Jin Kim, Sang-Won Lee, Donghyok Kwon; Osong Public Health Res Perspect. 2021;12(3):139-148. Published online June 24, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0037

4,482 View
140 Download
7 Citations

Abstract PDF

The variant B.1.1.7 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the RNA virus causing the pandemic more than a year worldwide, was reported from United Kingdom (UK) in late December 2020. It was reported that mortality increases by 65% and transmissibility increases by 70%, which may result in an increase of reproduction number to 1.13−1.55 from 0.75−0.85. To analyze the global increasing trend of the variant B.1.1.7, we extracted results of B.1.1.7 from GISAID on May 11 and May 12, 2021, and conducted a doseresponse regression. It took 47 days to reach 20% and 121 days to reach 50% among the sequence submitted from UK. In Korea, cases of B.1.1.7 have increased since the first report of three cases on December 28, 2020. Positive rate of B.1.1.7 in Korea was 21.6% in the week from May 9 to May 15, 2021. Detection rate of the variants is expected to increase further and new variants of SARS-CoV-2 are emerging, so a close monitoring and control would be maintained for months.

Citations

Citations to this article as recorded by

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Ahmed I. Abulsoud, Hussein M. El-Husseiny, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Ahmed Ismail, Samy Y. Elkhawaga, Emad Gamil Khidr, Doaa Fathi, Eman A. Mady, Agnieszka Najda, Mohammad Algahtani, Abdulrahman Theyab, Khalaf F. Alsharif, Ashraf Albrakati
Biomedicine & Pharmacotherapy.2023; 157: 113977. CrossRef
Incidence Evaluation of SARS-CoV-2 Variants in the Ulsan Area, Korea, Using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit: A Pilot Study
Sang Hyuk Park, Hyun-Ki Kim, Hang Kang, Jung Heon Kim, Jaeseung Lee, Ji-Hun Lim, Seon-Ho Lee, Joseph Jeong
Annals of Laboratory Medicine.2022; 42(3): 363. CrossRef
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines.2022; 10(6): 919. CrossRef
Virtual recruitment and participant engagement for substance use research during a pandemic
Carolin C. Hoeflich, Anna Wang, Ayodeji Otufowora, Linda B. Cottler, Catherine W. Striley
Current Opinion in Psychiatry.2022; 35(4): 252. CrossRef
Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface
Hongguan Xing, Liyan Zhu, Pingping Wang, Guoping Zhao, Zhihua Zhou, Yi Yang, Hong Zou, Xing Yan
Frontiers in Immunology.2022;[Epub] CrossRef
Mutations in SARS-CoV-2 nucleocapsid in variants of concern impair the sensitivity of SARS-CoV-2 detection by rapid antigen tests
Ibrahim T. Hagag, Krzysztof Pyrc, Saskia Weber, Anne Balkema-Buschmann, Martin H. Groschup, Markus Keller
Frontiers in Virology.2022;[Epub] CrossRef
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
Lixin Lin, Ying Liu, Xiujuan Tang, Daihai He
Frontiers in Public Health.2021;[Epub] CrossRef

Original Articles

Delays in the diagnosis and treatment of tuberculosis during the COVID-19 outbreak in the Republic of Korea in 2020: Jiyeon Yang, Yunhyung Kwon, Jaetae Kim, Yoojin Jang, Jiyeon Han, Daae Kim, Hyeran Jeong, Hyekyung Park, Eunhye Shim; Osong Public Health Res Perspect. 2021;12(5):293-303. Published online September 23, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0063

4,800 View
153 Download
6 Citations

Graphical Abstract Abstract PDF

Objectives
We investigated the impact of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis (TB) management in the Republic of Korea (ROK).
Methods
This retrospective cross-sectional study used nationwide ROK TB notification data (98,346 cases) from 2017 to 2020. The median time from the onset of TB symptoms to treatment initiation and the compliance rates with the required timing for notification and individual case investigations were measured and compared across periods and regions affected by the COVID-19 epidemic.
Results
TB diagnosis during the COVID-19 pandemic was delayed. The median time to TB treatment initiation (25 days) in 2020 increased by 3 days compared to that of the previous 3 years (22 days) (p<0.0001). In the outbreak in Seoul, Incheon, and Gyeonggi province during August, the time to TB diagnosis was 4 days longer than in the previous 3 years (p=0.0303). In the outbreak in Daegu and Gyeongbuk province from February to March 2020, the compliance rate with the required timing for individual case investigations was 2.2%p points lower than in other areas in 2020 (p=0.0148). For public health centers, the rate was 13%p lower than in other areas (80.3% vs. 93.3%, p=0.0003).
Conclusion
TB diagnoses during the COVID-19 pandemic in the ROK were delayed nationwide, especially for patients notified by public-private mix TB control hospitals. TB individual case investigations were delayed in regional COVID-19 outbreak areas (Daegu and Gyeongbuk province), especially in public health centers. Developing strategies to address this issue will be helpful for sustainable TB management during future outbreaks.

Citations

Citations to this article as recorded by

Tuberculosis: Republic of Korea, 2021
Jinsoo Min, Hyung Woo Kim, Ju Sang Kim
Tuberculosis and Respiratory Diseases.2023; 86(1): 67. CrossRef
Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study
Jinsoo Min, Yousang Ko, Hyung Woo Kim, Hyeon-Kyoung Koo, Jee Youn Oh, Yun-Jeong Jeong, Hyeon Hui Kang, Kwang Joo Park, Yong Il Hwang, Jin Woo Kim, Joong Hyun Ahn, Yangjin Jegal, Ji Young Kang, Sung-Soon Lee, Jae Seuk Park, Ju Sang Kim
Journal of Korean Medical Science.2022;[Epub] CrossRef
Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
Wang Yun, Chen Huijuan, Liao Long, Lu Xiaolong, Zhang Aihua
BMC Infectious Diseases.2022;[Epub] CrossRef
Real-world association of adherence with outcomes and economic burden in patients with tuberculosis from South Korea claims data
Sun-Hong Kwon, Jin Hyun Nam, Hye-Lin Kim, Hae-Young Park, Jin-Won Kwon
Frontiers in Pharmacology.2022;[Epub] CrossRef
The Impact of the COVID-19 Pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini
Hloniphile Victory Masina, I-Feng Lin, Li-Yin Chien
International Journal of Public Health.2022;[Epub] CrossRef
Trends in incidences of newly notified tuberculosis in Jeju Province, Korea, 2017-2021
Jinhee Kim, Nam-Hun Kang, Jong-Myon Bae
Journal of Medicine and Life Science.2022; 19(3): 103. CrossRef

Trends in recent waterborne and foodborne disease outbreaks in South Korea, 2015–2019: Sang Hyuk Lee, Jae-Won Yun, Ji Hee Lee, Yeon Haw Jung, Dong Han Lee; Osong Public Health Res Perspect. 2021;12(2):73-79. Published online April 29, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.12.2.04

4,189 View
138 Download
6 Citations

Abstract PDF

Objectives
This study analyzed trends in foodborne and waterborne diseases in South Korea between 2015 and 2019.
Methods
The data consisted of information on outbreaks of waterborne and foodborne infectious diseases reported through the Korea Centers for Disease Control and Prevention (KCDC) system. We analyzed the trends and epidemiological aspects of outbreaks by month, place of occurrence, and causative pathogens in this observational study.
Results
The number of outbreaks has steadily increased over the last 5 years, but the number of cases per outbreak has followed a decreasing trend. Incidence at daycare centers and preschools has been steadily increasing over consecutive years.
Conclusion
The steady number of patients and decreasing number of cases per outbreak, even as the number of outbreaks has been increasing, suggest that the KCDC’s professional management system is operating effectively. It is necessary to continue improving the objectivity and efficiency of the management system and to carefully examine the increasing number of outbreaks in smaller-scale group catering facilities, such as daycare centers and preschools. Outbreaks can be prevented by closely examining those caused by unidentified pathogens and group outbreaks caused by other diseases, identifying problems, and supplementing the management system.

Citations

Citations to this article as recorded by

Ultrasensitive quantification of pathogens in milliliters of beverage by filtration-based digital LAMP
Yuhua Yan, Tao Yang, Zisheng Luo, Dong Li, Li Li, Xingyu Lin
Food Chemistry.2023; 408: 135226. CrossRef
2022년 하절기 수인성 및 식품매개감염병 비상방역체계 운영결과
다슬 김, 인호 김, 형준 김, 지애 심, 지수 원, 진 곽
Public Health Weekly Report.2023; 16(2): 36. CrossRef
Survival of murine norovirus and hepatitis A virus in bottled drinking water, strawberries, and oysters
Ziwei Zhao, Md Iqbal Hossain, Soontag Jung, Zhaoqi Wang, Daseul Yeo, Mengxiao Song, Ae Min, Sunho Park, Changsun Choi
Food Control.2022; 133: 108623. CrossRef
Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
Soyeoun Kim, Jinhyun Kim, Bo Youl Choi, Boyoung Park
Epidemiology and Health.2022; 44: e2022011. CrossRef
Molecular Identification of Bacillus Isolated from Korean Water Deer (Hydropotes inermis argyropus) and Striped Field Mouse (Apodemus agrarius) Feces by Using an SNP-Based 16S Ribosomal Marker
Md-Mafizur Rahman, Sang-Jin Lim, Yung-Chul Park
Animals.2022; 12(8): 979. CrossRef
Trends in Acute Gastroenteritis through the Pathogen Surveillance System in Incheon Metropolitan City, 2018-2021
Jung Hee Kim, Sung Min Song, Ju Hee Kim, Soo Min Lim, Su Jin Park, Hwa Jung Nam, Young Woo Gong, Mun Ju Kwon
Journal of Bacteriology and Virology.2022; 52(2): 54. CrossRef

Global variation of COVID-19 mortality rates in the initial phase: Saman Hasan Siddiqui, Azza Sarfraz, Arjumand Rizvi, Fariha Shaheen, Mohammad Tahir Yousafzai, Syed Asad Ali; Osong Public Health Res Perspect. 2021;12(2):64-72. Published online April 29, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.12.2.03

4,105 View
142 Download
6 Citations

Abstract PDF Supplementary Material

Objectives
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused devastation in over 200 countries. Italy, Spain, and the United States (US) were most severely affected by the first wave of the pandemic. The reasons why some countries were more strongly affected than others remain unknown. We identified the most-affected and less-affected countries and states and explored environmental, host, and infrastructure risk factors that may explain differences in the SARS-CoV-2 mortality burden.
Methods
We identified the top 10 countries/US states with the highest deaths per population until May 2020. For each of these 10 case countries/states, we identified 6 control countries/states with a similar population size and at least 3 times fewer deaths per population. We extracted data for 30 risk factors from publicly available, trusted sources. We compared case and control countries/states using the non-parametric Wilcoxon rank-sum test, and conducted a secondary cluster analysis to explore the relationship between the number of cases per population and the number of deaths per population using a scalable EM (expectation–maximization) clustering algorithm.
Results
Statistically significant differences were found in 16 of 30 investigated risk factors, the most important of which were temperature, neonatal and under-5 mortality rates, the percentage of under-5 deaths due to acute respiratory infections (ARIs) and diarrhea, and tuberculosis incidence (p<0.05)
Conclusion
Countries with a higher burden of baseline pediatric mortality rates, higher pediatric mortality from preventable diseases like diarrhea and ARI, and higher tuberculosis incidence had lower rates of coronavirus disease 2019-associated mortality, supporting the hygiene hypothesis.

Citations

Citations to this article as recorded by

Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia
Yazed AlRuthia, Haya F. Al-Salloum, Omar A. Almohammed, Amani S. Alqahtani, Hana A. Al-Abdulkarim, Yousef M. Alsofayan, Sami S. Almudarra, Sara H. AlQahtani, Abdullah Almutlaq, Khaled Alabdulkareem, Bander Balkhi, Hamoud T. Almutairi, Abdullah S. Alanazi,
Vaccines.2022; 10(2): 323. CrossRef
Temporal variation, socioeconomic status, and out‐of‐hospital deaths as factors that influence mortality rates among hospitalized COVID‐19 patients receiving ACEIs/ARBs
Owais M. Aftab, Anurag Modak, Jai C. Patel
The Journal of Clinical Hypertension.2022; 24(4): 519. CrossRef
Coinfection of leptospirosis and coronavirus disease 2019: A retrospective case series from a coastal region in South India
Nitin Gupta, William Wilson, Prithvishree Ravindra, Roshini Raghu, Kavitha Saravu
Journal of Medical Virology.2022; 94(9): 4508. CrossRef
Dietary, comorbidity, and geo-economic data fusion for explainable COVID-19 mortality prediction
Milena Trajanoska, Risto Trajanov, Tome Eftimov
Expert Systems with Applications.2022; 209: 118377. CrossRef
Paraoxonase 1 rs662 polymorphism, its related variables, and COVID-19 intensity: Considering gender and post-COVID complications
Zohreh-Al-Sadat Ghoreshi, Mojtaba Abbasi-jorjandi, Gholamreza Asadikaram, Mohsen Sharif-zak, Fatemeh Seyedi, Mohammad Khaksari Haddad, Mohammadreza Zangouey
Experimental Biology and Medicine.2022; : 153537022211285. CrossRef
Variances in BCG protection against COVID-19 mortality: A global assessment
Zouina Sarfraz, Azza Sarfraz, Krunal Pandav, Sarabjot Singh Makkar, Saman Hasan Siddiqui, Gaurav Patel, Tania Platero-Portillo, Bishnu Mohan Singh, Mohamed Iburahim Haja Maideen, Deepika Sarvepalli, Muzna Sarfraz, Jose Cardona-Guzman, Marcos A. Sanchez-Go
Journal of Clinical Tuberculosis and Other Mycobac.2021; 24: 100249. CrossRef

Editorial

How to deal with the Delta variant this fall: Jong-Koo Lee; Osong Public Health Res Perspect. 2021;12(4):201-202. Published online August 26, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0217

2,816 View
69 Download
5 Citations

PDF

Citations

Citations to this article as recorded by

A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection
Mohsen Khosravi
Pharmacopsychiatry.2022; 55(01): 58. CrossRef
Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform
Jung Hun Ju, Naery Lee, Sun-hee Kim, Seokkee Chang, Misook Yang, Jihyun Shin, Eunjo Lee, Sunhwa Sung, Jung-Hwan Kim, Jin Tae Hong, Ho Jung Oh
Osong Public Health and Research Perspectives.2022; 13(1): 4. CrossRef
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
Chang Kyung Kang, Hyun Mu Shin, Pyoeng Gyun Choe, Jiyoung Park, Jisu Hong, Jung Seon Seo, Yung Hie Lee, Euijin Chang, Nam Joong Kim, Minji Kim, Yong-Woo Kim, Hang-Rae Kim, Chang-Han Lee, Jun-Young Seo, Wan Beom Park, Myoung-don Oh
BMC Medicine.2022;[Epub] CrossRef
Impact of national Covid-19 vaccination Campaign, South Korea
Seonju Yi, Young June Choe, Do Sang Lim, Hye Roen Lee, Jia Kim, Yoo-Yeon Kim, Ryu Kyung Kim, Eun Jung Jang, Sangwon Lee, Eunjoo Park, Seung-Jin Kim, Young-Joon Park
Vaccine.2022; 40(26): 3670. CrossRef
Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea
Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, Cheon Kwon Yoo, Eun-Jin Kim
Virology Journal.2022;[Epub] CrossRef

Original Articles

Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study: Zohreh Azarkar, Hamid Salehiniya, Toba Kazemi, Hamid Abbaszadeh; Osong Public Health Res Perspect. 2021;12(3):169-176. Published online May 26, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0012

3,875 View
107 Download
5 Citations

Abstract PDF

Objectives
Coronavirus disease 2019 (COVID-19) is a novel pandemic. Considerable differences in disease severity and the mortality rate have been observed in different parts of the world. The present study investigated the characteristics and outcomes of patients hospitalized with COVID-19 in Iran.
Methods
We established a retrospective cohort to study hospitalized COVID-19 patients in Iran. Epidemiological, imaging, laboratory, and clinical characteristics and outcomes were recorded from medical documents. The chi-square test, t-test, and logistic regression models were used to analyze the data. A p<0.05 was considered to indicate statistical significance.
Results
In total, 364 cases (207 males and 157 females) were analyzed. The most common symptoms were cough, fever, and dyspnea. Multifocal bilateral ground-glass opacities with peripheral distribution were the predominant imaging finding. The mean age of patients was 54.28±18.81 years. The mean age of patients who died was 71.50±14.60 years. The mortality rate was 17.6%. The total proportion of patients with a comorbidity was 47.5%, and 84.4% of patients who died had a comorbidity. Sex, history of diabetes mellitus, and dyslipidemia were not significantly associated with mortality (p>0.05). However, mortality showed significant relationships with body mass index; age; history of hypertension, chronic kidney disease (CKD), ischemic heart disease, cerebrovascular accident (CVA), pulmonary disease, and cancer; and abnormal high-resolution computed tomography (HRCT) findings (p<0.05 for all). Cancer had the highest odds ratio.
Conclusion
Comorbidities (especially cancer, CKD, and CVA), severe obesity, old age, and abnormal HRCT findings affected the health outcomes of patients hospitalized with COVID-19.

Citations

Citations to this article as recorded by

The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates
Shuwen Li, Jiahao Ren, Hongjie Hou, Xueya Han, Jie Xu, Guangcai Duan, Yadong Wang, Haiyan Yang
Neurological Sciences.2022; 43(7): 4049. CrossRef
Mental health status of dentists during COVID‐19 pandemic: A systematic review and meta‐analysis
Hamid Salehiniya, Sare Hatamian, Hamid Abbaszadeh
Health Science Reports.2022;[Epub] CrossRef
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
Lamiaa A Fathalla, Lamyaa M Kamal, Omina Salaheldin, Mahmoud A Khalil, Mahmoud M Kamel, Hagar H Fahim, Youssef AS Abdel-Moneim, Jawaher A Abdulhakim, Ahmed S Abdel-Moneim, Yomna M El-Meligui
International Journal of Immunopathology and Pharm.2022; 36: 039463202210962. CrossRef
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
Mehmet Emin Arayici, Nazlican Kipcak, Ufuktan Kayacik, Cansu Kelbat, Deniz Keskin, Muhammed Emin Kilicarslan, Ahmet Veli Kilinc, Sumeyye Kirgoz, Anil Kirilmaz, Melih Alihan Kizilkaya, Irem Gaye Kizmaz, Enes Berkin Kocak, Enver Kochan, Begum Kocpinar, Fatm
Journal of Cancer Research and Clinical Oncology.2022;[Epub] CrossRef
Obesity and Infection: What Have We Learned From the COVID-19 Pandemic
Emilia Vassilopoulou, Roxana Silvia Bumbacea, Aikaterini Konstantina Pappa, Athanasios N. Papadopoulos, Dragos Bumbacea
Frontiers in Nutrition.2022;[Epub] CrossRef

The 100 top-cited articles on scrub typhus: a bibliometric analysis: Taha Hussein Musa, Wei Li, Joseph Kawuki, Pingmin Wei; Osong Public Health Res Perspect. 2021;12(2):126-135. Published online April 29, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.12.2.10

3,470 View
95 Download
5 Citations

Abstract PDF Supplementary Material

Objectives
The aims of this study were to analyze the characteristics of the 100 top-cited articles on scrub typhus (ST), and to assess the present research landscape and future research directions using bibliometric analysis.
Methods
Web of Science was used to conduct a bibliometric analysis of the 100 top-cited articles on ST. The articles were analyzed by publication year, number of citations, document type, journals, keywords, institutions, country of origin, and authorship.
Results
The top 100 articles on ST were published between 1945 to 2017. The number of citations ranges from 39 to 227 and the interquartile range was 35.5. The United States published the highest number (n=21) of articles. Mahidol University was the most prolific institution in terms of articles (n=14). The American Journal of Tropical Medicine and Hygiene was the journal with the most articles (n=14), and Paris DH was the most productive author in terms of the Hirsh-index, which was 10 for that author. The study revealed a significant correlation between the total number of citations and the number of authors (r=0.668, p<0.001), number of institutions (r=0.692, p<0.001), number of years since publication (r=0.869, p<0.001), and number of countries involved (r=0.963, p<0.001).
Conclusion
The findings of this study provide landmarks in the publication and citation frequency of the most influential articles on ST. In addition, this study provides useful information for readers and health policy-makers in evaluating the literature on ST.

Citations

Citations to this article as recorded by

The 100 top-cited articles on childhood obesity: a bibliometric analysis
Joseph Kawuki, Taha Hussein Musa, Upama Ghimire, Nathan Obore, Shireen Salome Papabathini
Global Health Journal.2022; 6(3): 136. CrossRef
Cancer and COVID-19 research studies with team science: a bibliometric study
Arezoo Ghamgosar, Sirous Panahi, Leila Nemati-Anaraki
Journal of Interprofessional Care.2022; : 1. CrossRef
The associations between scientific collaborations of LIS research and its policy impact
Zhihong Huang, Qianjin Zong, Xuerui Ji
Scientometrics.2022; 127(11): 6453. CrossRef
A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database
Hassan H. Musa, Taha H. Musa
Human Vaccines & Immunotherapeutics.2022;[Epub] CrossRef
The 100 Most Cited Articles on Dental Anomalies: a bibliometric analysis
Glenda VİEİRA DE SOUSA, Maria Eduarda FERREİRA DE SOUZA, Eloísa CESÁRİO, Patrícia SANTOS
Cumhuriyet Dental Journal.2022;[Epub] CrossRef

Impact of fatigue on quality of life among breast cancer patients receiving chemotherapy: Fares Mohammed Saeed Muthanna, Mahmathi Karuppannan, Bassam Abdul Rasool Hassan, Ali Haider Mohammed; Osong Public Health Res Perspect. 2021;12(2):115-125. Published online April 29, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.12.2.09

5,221 View
229 Download
5 Citations

Abstract PDF

Objectives
Fatigue is the most frequently reported symptom experienced by cancer patients and has a profound effect on their quality of life (QOL). The study aimed to determine the impact of fatigue on QOL among breast cancer patients receiving chemotherapy and to identify the risk factors associated with severe fatigue incidence.
Methods
This was an observational prospective study carried out at multiple centers. In total, 172 breast cancer patients were included. The Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire was used to measure QOL, while the Brief Fatigue Inventory (BFI) was used to assess the severity of fatigue.
Results
The total average mean and standard deviation of QOL were 84.58±18.07 and 4.65±1.14 for BFI scores, respectively. A significant association between fatigue and QOL was found in linear and multiple regression analyses. The relationships between fatigue severity and cancer stage, chemotherapy dose delay, dose reduction, chemotherapy regimen, and ethnicity were determined using binary logistic regression analysis.
Conclusion
The findings of this study are believed to be useful for helping oncologists effectively evaluate, monitor, and treat fatigue related to QOL changes.

Citations

Citations to this article as recorded by

Anatomical Sites OF Superficial Basal Cell Cancers Demonstrate Higher Rates of Mixed Histology
Zahid Sarfaraz Khan, Asim Muhammad, Muhammad Ataullah, Syeda Gulrukh Saba Shah, Tehmina Naushin, Hina Mir, Nabiha Naeem, Ziyad Ahmad, Sudhair Abbas Bangash, Irfan Ullah
Pakistan BioMedical Journal.2022; : 44. CrossRef
Glycated Albumin's Clinical Effectiveness in The Diabetes Diagnosis
Summeira Jabeen Shah, Hajira Ishaq, Hina Hakeem, Saima Shaheen, Sikandar Ali Khan, Sosan Rauf, Hina Mir, Sudhair Abbas Bangash, Muhammad Ali, Irfan Ullah
Pakistan BioMedical Journal.2022; : 176. CrossRef
Post stroke intervention trial in fatigue (POSITIF): Randomised multicentre feasibility trial
Gillian Mead, David Gillespie, Mark Barber, Allan House, Steff Lewis, Hannah Ensor, Simiao Wu, Trudie Chalder
Clinical Rehabilitation.2022; 36(12): 1578. CrossRef
Quality of Life and Its Associated Factors Among Cancer Patients Receiving Chemotherapy at Oncology Hospitals in Vietnam After the Third Wave of the COVID-19 Pandemic
Hanh TH Nguyen, Khanh Linh Duong, Son T Nguyen, Quy Trinh, Hao TL Hoang, Toan Q Phung, Hsiang-Wen Lin, Huong TL Nguyen
Cancer Management and Research.2022; Volume 14: 2429. CrossRef
Effects of traditional Chinese medicine exercise therapy on cancer-related fatigue, anxiety and sleep quality in cancer patients
Lihao Jiang, Ju Ouyang, Xianfeng Du
Medicine.2021; 100(44): e27681. CrossRef

Review Article

Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children: Milad Zandi, Saber Soltani, Mona Fani, Samaneh Abbasi, Saeedeh Ebrahimi, Ali Ramezani; Osong Public Health Res Perspect. 2021;12(5):286-292. Published online October 1, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0140

4,256 View
148 Download
4 Citations

Abstract PDF

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.

Citations

Citations to this article as recorded by

Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020
Thomas Williams, Sandra Jackson, Ian Barr, Shabana Bi, Jinal Bhiman, Joanna Ellis, Anne von Gottberg, Stephen Lindstrom, Teresa Peret, Sanjiv Rughooputh, Mariana Viegas, Siddhivinayak Hirve, Maria Zambon, Wenqing Zhang, Ndongo Dia, Norosoa Razanazatovo, A
Influenza and Other Respiratory Viruses.2023;[Epub] CrossRef
Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
Elly Binns, Jane Tuckerman, Paul V Licciardi, Danielle Wurzel
Journal of Paediatrics and Child Health.2022; 58(10): 1741. CrossRef
Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children
Laura Elena Córdova-Dávalos, Alicia Hernández-Mercado, Claudia Berenice Barrón-García, Augusto Rojas-Martínez, Mariela Jiménez, Eva Salinas, Daniel Cervantes-García
Virus Genes.2022; 58(6): 501. CrossRef
Clinical and epidemiological characteristics of SARS-CoV-2 virus in ambulatory children under 2 years old
Carolina A. Perez, Ivana Ormazabal, Javier Pérez-Valenzuela, Andrea Araya, Rafael A. Medina, Cecilia Perret
Frontiers in Pediatrics.2022;[Epub] CrossRef

Brief Report

COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021: Hyun-kyung Oh, Eun Kyeong Kim, Insob Hwang, Tae Eun Kim, Yeon-kyeong Lee, Eunju Lee, Yeon-Kyeng Lee; Osong Public Health Res Perspect. 2021;12(4):264-268. Published online August 13, 2021; DOI: https://doi.org/10.24171/j.phrp.2021.0157

3,838 View
123 Download
4 Citations

Abstract PDF

Objectives
On February 26, 2021, coronavirus disease 2019 (COVID-19) vaccination was started for high-priority groups based on the recommendation of the Advisory Committee on Immunization Practices with 2 available COVID-19 vaccines (AstraZeneca and Pfizer-BioNTech) in Korea. This report provides a summary of adverse events following COVID-19 vaccination as of April 30, 2021.
Methods
Adverse events following immunization are notifiable by medical doctors to the Korea Immunization Management System (KIMS) under the national surveillance system. We analyzed all adverse events reports following COVID-19 vaccination to the KIMS from February 26 to April 30, 2021.
Results
In total, 16,196 adverse events following 3,586,814 administered doses of COVID-19 vaccines were reported in approximately 2 months (February 26 to April 30, 2021). Of these, 15,658 (96.7%) were non-serious adverse events, and 538 (3.3%) were serious adverse events, including 73 (0.5%) deaths. The majority of adverse events (n=13,063, 80.7%) were observed in women, and the most frequently reported adverse events were myalgia (52.2%), fever (44.9%), and headache (34.9%). Of the 73 deaths following the COVID-19 vaccination, none were related to the vaccines.
Conclusion
By April 30, 3.6 million doses of the COVID 19 vaccine had been given in Korea, and the overwhelming majority of reports were for non-serious events. The Korea Disease Control and Prevention Agency continues to monitor the safety of COVID-19 vaccination.

Citations

Citations to this article as recorded by

Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents
Young June Choe, Seonju Yi, Insob Hwang, Jia Kim, Young-Joon Park, Eunhee Cho, Myoungyoun Jo, Hyunju Lee, Eun Hwa Choi
Vaccine.2022; 40(5): 691. CrossRef
Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey
Minjung Lee, Myoungsoon You
Journal of Medical Internet Research.2022; 24(1): e32329. CrossRef
Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
Lama T AlMutairi, Wesal Y Alalayet, Sondus I Ata, Khalidah A Alenzi, Yazed AlRuthia
Vaccines.2022; 10(6): 977. CrossRef
COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021
Insob Hwang, Kyeongeun Park, Tae Eun Kim, Yunhyung Kwon, Yeon-Kyeng Lee
Osong Public Health and Research Perspectives.2021; 12(6): 396. CrossRef

First
Prev
Page of 3
Next
Last

Most cited